{"title":"肿瘤干细胞在三阴性乳腺癌中的研究进展","authors":"Ye Kang, Jianyi Li, Xiang-Hong Yang","doi":"10.3760/CMA.J.ISSN.1673-422X.2019.06.010","DOIUrl":null,"url":null,"abstract":"There are abundant cancer stem cells (CSCs) in triple-negative breast cancer (TNBC). CSCs can maintain their phenotype by unique molecular mechanism and tumor microenvironment, and can promote the chemotherapy resistance and recurrence of TNBC. Blocking these key molecules or altering tumor microenvironment can reduce CSCs, and then inhibited cancer growth and reverse chemotherapy resistance of TNBC. \n \n \nKey words: \nBreast neoplasms; Neoplastic stem cells; Therapy; Drug resistance; Triple negative breast neoplasms","PeriodicalId":16120,"journal":{"name":"国际肿瘤学杂志","volume":"44 1","pages":"362-365"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Research progress of cancer stem cells in triple-negative breast cancer\",\"authors\":\"Ye Kang, Jianyi Li, Xiang-Hong Yang\",\"doi\":\"10.3760/CMA.J.ISSN.1673-422X.2019.06.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"There are abundant cancer stem cells (CSCs) in triple-negative breast cancer (TNBC). CSCs can maintain their phenotype by unique molecular mechanism and tumor microenvironment, and can promote the chemotherapy resistance and recurrence of TNBC. Blocking these key molecules or altering tumor microenvironment can reduce CSCs, and then inhibited cancer growth and reverse chemotherapy resistance of TNBC. \\n \\n \\nKey words: \\nBreast neoplasms; Neoplastic stem cells; Therapy; Drug resistance; Triple negative breast neoplasms\",\"PeriodicalId\":16120,\"journal\":{\"name\":\"国际肿瘤学杂志\",\"volume\":\"44 1\",\"pages\":\"362-365\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"国际肿瘤学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1673-422X.2019.06.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"国际肿瘤学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-422X.2019.06.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Research progress of cancer stem cells in triple-negative breast cancer
There are abundant cancer stem cells (CSCs) in triple-negative breast cancer (TNBC). CSCs can maintain their phenotype by unique molecular mechanism and tumor microenvironment, and can promote the chemotherapy resistance and recurrence of TNBC. Blocking these key molecules or altering tumor microenvironment can reduce CSCs, and then inhibited cancer growth and reverse chemotherapy resistance of TNBC.
Key words:
Breast neoplasms; Neoplastic stem cells; Therapy; Drug resistance; Triple negative breast neoplasms